Intensive Statin Therapy - A Sea Change in Cardiovascular Prevention

New England Journal of Medicine

Volumn 350, Issue 15, 2004, Pages 1562-1564

  Topol, Eric J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DRUG COST; DRUG EFFECT; DRUG EFFICACY; EDITORIAL; HEART PROTECTION; HUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANGINA, UNSTABLE; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, LDL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MYOCARDIAL INFARCTION; PRAVASTATIN; PYRROLES;

EID: 1842765431     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe048061     Document Type: Editorial

References (13)

1. Scandinavian Sinvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.
2. Roberts WC. The underused miracle drugs: the statin drugs are to atherosclerosis what penicillin was to infectious disease. Am J Cardiol 1996;78:377-8.
3. Brown MS, Goldstein JL. Heart attacks: gone with the century. Science 1996;272:629.
4. Heart Protection Study Collaboration Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
5. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. Circulation 2002;106:3143-421.
6. Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-80.
7. Winslow R. Study signals how low to go on cholesterol. Wall Street Journal. November 13, 2003:D1.
8. Kolata G. Study of two cholesterol drugs finds one halts heart disease. New York Times. November 13, 2003:A1.
9. Head-to-head drug combat. New York Times. November 16, 2003(Section 4):12.
10. Cannon CP, Braunwald E, McCabe CH, et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-504.
11. Ford ES, Mokdad AH, Giles WH, Mensah GA. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185-9.
12. Wilde Mathews A, Landers P. An FDA shift could transform market for statins: agency will consider allowing over-the-counter sales of cholesterol medicine. Wall Street Journal. November 12, 2003:A1.
13. Harris G. 2 Cancer drugs, no comparative data. New York Times. February 26, 2004:C1.